More participants in the higher-dose group than placebo achieved an HbA1c under 7% (55.9% vs 15.2%) or under 6.5% (29.4% vs 6 ...

Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...

California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.

This growth comes on the back of a steady market performance from 2017 to 2022, where the injection pen sector achieved a ...

Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...

A team of researchers has made a breakthrough in diabetes treatment, uncovering a way to regenerate human insulin-producing ...

Just nine weeks after UnitedHealthcare CEO Brian Thompson was murdered on a weekday morning on a busy street, the luminaries ...

Lexicon's non-opioid drug pilavapadin fails Phase 2b pain trial at 20mg dose, but shows promise at 10mg. Company plans Phase ...

UK-based specialty drugmaker Kelso Pharma has appointed experienced pharma executive, Giovanni Mauri, as general manager at ...

Valbiotis unveils its annual financial statements and confirms its strategic and financial goals VALBIOTIS SA VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms ...